Mangalam Drugs & Organics has informed that the 'Company along with the other appellants' ('Appellants'), have challenged the order dated September 22 2020, passed by the Whole time member ('WTM') of Securities and Exchange Board of India SEBI (SEBI), before Securities Appellate Tribunal ('SAT'). In continuation of that, an order was pronounced by the SAT. In terms of the order passed by the SAT, the impugned order passed by the SEBI against the Company cannot be sustained and hence quashed. The Copy of the SAT order is herewith attached for your reference. The Company is in the process of receiving the Certified Copy of the Order from the Registry.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1619.95 |
| Dr. Reddys Lab | 1315.85 |
| Cipla | 1294.75 |
| Zydus Lifesciences | 927.15 |
| Lupin | 2296.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: